ACTIVE SPECIFIC IMMUNOTHERAPY FOR OVARIAN CANCER
- 1 October 1976
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 308 (7991), 877-879
- https://doi.org/10.1016/s0140-6736(76)90539-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Management of Ovarian CarcinomaNew England Journal of Medicine, 1976
- PROLONGATION OF POSTOPERATIVE DISEASE-FREE INTERVAL AND SURVIVAL IN HUMAN COLORECTAL CANCER BY B.C.G. OR B.C.G. PLUS 5-FLUOROURACILThe Lancet, 1976
- Tumour antigenicity in ovarian cancerBritish Journal of Cancer, 1975
- Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot studyBritish Journal of Cancer, 1975
- Immunotherapy for Acute Myelogenous LeukaemiaBritish Journal of Cancer, 1973
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataPublished by JSTOR ,1973
- Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating AntigenBritish Journal of Cancer, 1972
- Demonstration of cell‐mediated immunity to human neoplasms of various histological typesInternational Journal of Cancer, 1971
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- CANCER OF THE OVARYAmerican Journal of Roentgenology, 1968